ABSTRACT
Introduction
In order to make renal transplants feasible, renovascular procedures, in some cases of renal lithiasis and nephron-sparing surgery, kidney ischemia must be produced; however, lesions due to ischemic and reperfusion procedures surmount more than 50% of acute renal insufficiency cases 1 . The greater the complexity of the small renal tumors, the greater the duration of ischemia required to excise it 2 .
The kidney has low tolerance to ischemia; human solitary kidneys afford no more than 20 minutes on cold ischemia and no more than 35 minutes on warm ischemia 3 . Ischemia reversibility hinges on three variables: histology after reperfusion, ATP regeneration capabilities, and the ability to keep intracellular calcium homeostasis 4, 5 . Assessing the causes of acute renal failure secondary to acute tubular necrosis, postoperative ischemic factor emerges as the main cause and is related to greater severity and mortality 6 . Some pharmacological interventions can improve the clinical conditions in surgical procedures involving the phenomenon of ischemia and reperfusion, and, among the pharmacological preconditioning options, there is chlorpromazine. This drug is a phenothiazine with anesthetic properties, adrenolytic effect and action on the Na + / K + -ATPase. The use of chlorpromazine had protective effect on the occurrence of renal failure in kidney transplant and tests that induced ischemia to kidney [7] [8] [9] .
The purpose of this analysis is to examine the influence of chlorpromazine on renal histology of rats submitted to ischemia and reperfusion injury.
Methods
This study occurred within the premises of Medical Research Institute, Faculdade Evangélica do Paraná (FEPAR). It had been approved by the Ethics Commission on Animal Use, FEPAR, under approval number 6953/2014.
The sample was based on 16 three-month old Wistar male rats (Rattus novergicus albinus, Rodentia mammalia), weighting 322.5 ± 5.6g. They had been split in two groups and the test solution was administrated through caudal vein by 3 mg/kg:
• Control group -CG (n=8): ischemia with isotonic saline solution.
• Chlorpromazine group -CPZ (n=8): ischemia with chlorpromazine (Longactil 
Surgical procedure
The animals were anesthetized with xylazine 2%, 10 mg/ kg, (Dorcipec Such procedure occurred as follows:
• Zero: resection of left kidney lower third with scalpel -which set the histological standard previous to ischemia, and hemostasis review of resected renal bed with electrocautery;
• 2 minutes after resection of left kidney lower third:
test solution infusion (chlorpromazine or isotonic saline solution);
• 15 minutes after test-drug administration: renal blood flow occlusion by vascular microclamp (Aesculap
including both renal vein and renal artery;
• 60 minutes of renal blood flow oclusion: left kidney reperfusion through microclamp removal, followed by hemostasis review and suture of abdominal wall;
• 24 hours after de main procedure: total left nephrec- 
Histopathology analysis
The left kidney was dissected and sectioned transversely close to its hilum and each unit fixed in 10% formalin buffered. (Table 1) . 
Results
Histological findings on inferior renal pole were peritubular capillary congestion, hydropic degeneration and interstitial edema that occurred in 25% of the sample, and without statistical significance.
The histopathology findings determined by 60-minutes ischemia which were present in all cases have been: tubular cylinders, hydropic degeneration, and peritubular capillary congestion. The observation of statistical significance in item peritubular capillary congestion was due to stratification of degrees of renal injury; in this regard, were more severe in the control group. Table 2 shows the statistical analysis of the histological patterns studied. In Figure 4 , chlorpromazine administration previous to renal ischemia induction is shown to completely reduce leukocyte accrual in vasa recta. 
Peritubular capillary congestion and leukocyte infiltration
in vasa recta renis ( Figure 5 ). 
Discussion
Diagnostic equipment technologic development has been providing new findings of ever smaller renal tumors in young individuals, therefore making way to needs of nephron sparing during surgical procedures towards removing such tumors; and partial nephrectomy relates to renal ischemia in order to allow nodule or renal mass removals; and, in order to prevent acute tubular necrosis, damage reduction due to blockage of renal blood flow -one of its main causes -must be attempted 2, 3 . Ischemia already is per se, rather damaging -however, ischemic tissue perfusion may lead to a whole series of problems, increasing tissue lesions, and, when related to systemic complications, it may develop in life-threatening situations for the patient. Oxygen reaction after perfusion leads to tissue damage and starts chain reactions of harmful cell responses previous to inflammation, cell death, and, at last, organ insufficiency
.
Usage of nephroprotective drugs minimizes renal ischemia damage; and, chlorpromazine does leave this clinical potential. This benefit can be caused by the generalized vasodilation with improved blood flow caused by chlorpromazine 4 . Chlorpromazine has anesthetic properties and sympatholytic effects that lead to inhibition of calcium influx, the inactivation of phospholipase and the inhibition of Na + / K + -ATPase, determining the increase in renal blood flow and restoring urine flow. These actions result in improved cell function after ischemia due to cellular energy metabolism modulation of oxidative stress 7, 12, 13 . Its protective action against ischemic lesions only occurs when it is administrated before the moment when there is blood flow interruption to the tissue; chlorpromazine is related to ATP recovery levels, calcium metabolism, and, losses of phospholipids 4 . During ischemia, significant alterations within intracellular calcium levels have not been observed; however, during reperfusion, larges amounts of this ion enter into the cellswhich does not occur so intensively in animals previously treated with chlorpromazine 7 . Studies evaluating the chlorpromazine as a protective agent began in 1966 7 and progressed in the 1970s 8, 9 and in the 1980s 12, 14 . From 2001 onwards, new publications, produced in Brazil, have emerged and they show the beneficial usage of chlorpromazine in renal ischemia episodes induced towards renal transplant 13, 15, 16, 18 . The last publication about chlorpromazine was published in 2010 18 , and for this reason new studies are necessary to confirm the benefits of this drug in renal ischemia; it's a cheap and easy-to-use drug.
Araujo's experiment has been used as model for this study; periods of time and medication dosage followed such model: chlorpromazine administration 15 minutes prior to renal blood flow obstruction, 60 minutes warm ischemia, post-24 hours damage evaluation, and, 3 mg/kg chlorpromazine dosage 15 . Distinctively, however, from the functional evaluation on that study, ischemia damage histological evaluation has been preferred. Reasons for such rely on the fact that the right kidney had been preservedthus interfering on results of serum analysis of creatinine and urea.
Chlorpromazine study findings have been, mainly, functional: scintigraphic changes or creatinine and urea counts 15 . There have also been studies towards lipid peroxidation (malondialdehyde count) 16 ; however, such study has alternatively focused on a number of histological items caused by ischemia related to renal architecture and chlorpromazine protective action.
When evaluating ischemia, there is a cell lesion triad related to phospholipid cell membrane, ATP and calcium 4 . When chlorpromazine acts on cell metabolism under ischemia, it manages to reduce sublethal and lethal cell damage for it possesses action mechanisms of action over such triad; which explains the decrease on peritubular capillary congestion and on leukocyte accrual in vasa recta renis.
When stabilizing lipid cell membranes, chlorpromazine encourages a decrease on the concentration of toxic aldehydes within cell environment secondary to lipid peroxidation, decreasing the arachidonic acid cycle. Therefore there is a reduction on the generation of chemotactic factors which might lead to leukocyte accumulation in the ischemic bed. Furthermore, once chlorpromazine decreases Na + /K + -ATPase activity and blocks the calcium channels, it will incur on lower hydrogen release within the respiratory chain, allowing for intracellular pH maintenance, and a decrease on aldehyde toxicity 17 . Yet another advantage of the preservation of Na + / K + -ATPase, and, of the faster hydrogen ion transfer from the mitochondria through respiratory chain stimulus, is the decrease of intra-renal ischemia caused by tubuloglomerular feedback and by sublethal endothelial lesion 1, 17 . Consequently, the peritubular capillary congestion, present within all evaluated kidneys, occurred not so intensively in the animals which had received chlorpromazine previous to induced ischemia.
The absence of lethal lesions within this experiment goes accordingly some citations that suggest the possibility that kidneys of rats can support a longer period of ischemia 19 . Shorter periods of time have been chosen due to the fact renal lesion from warm ischemia from periods longer than 60-minutes had been observed during the pilot experiment, and, due to the fact most studies regarding chlorpromazine used this timeframe. Within this pilot experiment, transversal serial sections in rat kidneys have been carried out in progressions of 15, 30, 45 and 60 minutes; and, such material was sent to routine histological processing, evaluating alterations resulting from 60 minutes of renal ischemia.
Some limitation of this study: the short follow-up -the left nephrectomy could be performed in a week or more; the comparison could be done also with the contralateral kidney of the same rat. In the future, its usefulness in kidney surgery should be tested by randomized clinical trials.
Conclusion
The administration of chlorpromazine 15 minutes before the obstruction of the renal blood flow in rats reduced the incidence of ischemic lesions.
